Posts by: Alice Melão

News

The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment of metastatic melanoma. The study, called PISCES, is part of ... Read more

March 9, 2017

Parkinson’s and Melanoma Link May Be Explained by ‘Red-Hair Gene’ Variant

News

Researchers have found that the melanocortin 1 receptor (MC1R) gene is needed to protect neurons from damaging toxins and for the production of dopamine in the brain, two characteristics that ... Read more

February 28, 2017

Gut Bacteria Composition May Determine Melanoma Patients’ Response to Anti-PD-1 Immunotherapy

News

The presence of a specific bacteria in the gut of patients with melanoma, as well as a greater diversity of gut bacteria, are associated with a better response to anti-PD-1 ... Read more

February 23, 2017

Study IDs Mechanism Underlying Metastatic Behavior in Melanoma Cells

News

Researchers have identified a cellular pathway that regulates the ability of melanoma cells to migrate to other parts of the body. This newly discovered mechanism may lead to the development of new targeted ... Read more

December 13, 2016December 13, 2016

Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

News

Alcohol consumption is associated with a moderate increase in the risk of developing melanoma, according to the findings of a recent study published in the Cancer Epidemiology, Biomarkers & Prevention, a ... Read more

November 29, 2016November 29, 2016

Virtual Clinical Trial Model Seen to Predict Real Responses of Melanoma Patients to Therapies

News

Researchers with Moffitt Cancer Center developed a computational framework that, they say, can accurately predict patient responses to cancer treatments in a virtual clinical trial, called phase i. This new methodology integrates actual patient ... Read more

November 6, 2016December 6, 2016

Immunotherapies Should Be First-Line Treatment of High-risk Melanomas, Study Says

News

Patients with advanced melanoma have improved survival rates with superior safety when treated with protocols that combine immunotherapy options, researchers recommended. The study, “Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: ... Read more

September 22, 2016

Using High-Factor Sunscreen Can Markedly Reduce Melanoma Risk

News

The use of high-factor sunscreen can decrease the risk of developing melanoma, according to a study published recently in the Journal of Clinical Oncology. The study, “Sunscreen Use and Subsequent Melanoma ... Read more